|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
MA24512A1
(fr)
|
1996-01-17 |
1998-12-31 |
Univ Vermont And State Agrienl |
Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
|
|
JP4213224B2
(ja)
|
1997-05-02 |
2009-01-21 |
ジェネンテック，インコーポレーテッド |
ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法
|
|
AT411997B
(de)
|
1999-09-14 |
2004-08-26 |
Baxter Ag |
Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
|
|
PT1355919E
(pt)
|
2000-12-12 |
2011-03-02 |
Medimmune Llc |
Moléculas com semivida longa, composições que as contêm e suas utilizações
|
|
US7297336B2
(en)
|
2003-09-12 |
2007-11-20 |
Baxter International Inc. |
Factor IXa specific antibodies displaying factor VIIIa like activity
|
|
AU2003271174A1
(en)
|
2003-10-10 |
2005-04-27 |
Chugai Seiyaku Kabushiki Kaisha |
Double specific antibodies substituting for functional protein
|
|
WO2005035754A1
(ja)
|
2003-10-14 |
2005-04-21 |
Chugai Seiyaku Kabushiki Kaisha |
機能蛋白質を代替する二重特異性抗体
|
|
EP3050963B1
(en)
|
2005-03-31 |
2019-09-18 |
Chugai Seiyaku Kabushiki Kaisha |
Process for production of polypeptide by regulation of assembly
|
|
CA2603264C
(en)
|
2005-04-08 |
2017-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody substituting for function of blood coagulation factor viii
|
|
KR20080030960A
(ko)
|
2005-07-05 |
2008-04-07 |
글락소 그룹 리미티드 |
Ｎｏｇｏ―ａ에 특이적인 인간화된 항체 및 이의 약제학적용도
|
|
US8871912B2
(en)
|
2006-03-24 |
2014-10-28 |
Merck Patent Gmbh |
Engineered heterodimeric protein domains
|
|
US20080102065A1
(en)
*
|
2006-04-14 |
2008-05-01 |
Borges Luis G |
Erythropoietin receptor extended duration limited agonists
|
|
JP5816170B2
(ja)
|
2009-06-26 |
2015-11-18 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体
|
|
KR101856792B1
(ko)
*
|
2009-12-25 |
2018-05-11 |
추가이 세이야쿠 가부시키가이샤 |
폴리펩티드 다량체를 정제하기 위한 폴리펩티드의 개변방법
|
|
US9527926B2
(en)
|
2010-05-14 |
2016-12-27 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
|
PH12016502073B1
(en)
*
|
2010-11-17 |
2024-04-05 |
Chugai Pharmaceutical Co Ltd |
Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
|
|
US20140356377A1
(en)
|
2011-08-25 |
2014-12-04 |
Umc Utrecht Holding B.V. |
Compounds for use in boosting coagulation
|
|
SI2838917T1
(sl)
|
2012-04-20 |
2019-11-29 |
Merus Nv |
Postopki in sredstva za produkcijo heterodimernih IG-podobnih molekul
|
|
EP2906599B1
(en)
|
2012-10-12 |
2019-07-17 |
Agency For Science, Technology And Research |
Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics
|
|
RU2687043C2
(ru)
*
|
2013-04-29 |
2019-05-06 |
Ф. Хоффманн-Ля Рош Аг |
МОДИФИЦИРОВАННЫЕ АСИММЕТРИЧНЫЕ АНТИТЕЛА, СВЯЗЫВАЮЩИЕ Fc-РЕЦЕПТОР, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
|
CN105848668A
(zh)
|
2013-11-04 |
2016-08-10 |
加利福尼亚大学董事会 |
治疗或预防与出血或低凝血相关联的病状的疗法
|
|
BR112016015140A2
(pt)
|
2013-12-30 |
2018-01-23 |
Epimab Biotherapeutics Inc. |
imunoglobulina com fabs in-tandem e usos das mesmas
|
|
TWI831106B
(zh)
|
2014-06-20 |
2024-02-01 |
日商中外製藥股份有限公司 |
用於因第viii凝血因子及/或活化的第viii凝血因子的活性降低或欠缺而發病及/或進展的疾病之預防及/或治療之醫藥組成物
|
|
TWI700300B
(zh)
|
2014-09-26 |
2020-08-01 |
日商中外製藥股份有限公司 |
中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
|
|
CA2978038A1
(en)
|
2015-04-17 |
2016-10-20 |
F. Hoffmann-La Roche Ag |
Combination therapy with coagulation factors and multispecific antibodies
|
|
JP2018123055A
(ja)
|
2015-04-24 |
2018-08-09 |
公立大学法人奈良県立医科大学 |
血液凝固第ｖｉｉｉ因子（ｆｖｉｉｉ）の機能を代替する多重特異性抗原結合分子を含有する、血液凝固第ｘｉ因子（ｆｘｉ）異常症の予防および／または治療に用いられる医薬組成物
|
|
EP3313871A1
(en)
*
|
2015-06-26 |
2018-05-02 |
Institute for Research in Biomedicine |
Proteins comprising a mutated lair-1 fragment and uses thereof
|
|
JP6920293B2
(ja)
|
2015-10-30 |
2021-08-18 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ＩｇＧ軽鎖におけるＮ末端切断の防止
|
|
US20200270363A1
(en)
|
2015-12-25 |
2020-08-27 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody having enhanced activity, and method for modifying same
|
|
WO2017132827A1
(en)
*
|
2016-02-02 |
2017-08-10 |
Innovent Biologics (Suzhou) Co., Ltd. |
Pd-1 antibodies
|
|
RU2767329C2
(ru)
|
2016-02-06 |
2022-03-17 |
Эпимаб Биотерапьютикс, Инк. |
Иммуноглобулин с тандемными fab-фрагментами и варианты его применения
|
|
CN109563154B
(zh)
|
2016-05-16 |
2024-12-13 |
武田药品工业株式会社 |
抗帕多瓦因子ix抗体
|
|
KR102591955B1
(ko)
*
|
2016-07-29 |
2023-10-19 |
추가이 세이야쿠 가부시키가이샤 |
증강된 fviii 보인자 기능 대체 활성을 갖는 이중특이성 항체
|
|
RU2766233C2
(ru)
|
2016-09-06 |
2022-02-10 |
Чугаи Сейяку Кабусики Кайся |
Способы применения биспецифического антитела, которое распознает фактор свертывания ix и/или активированный фактор свертывания ix и фактор свертывания x и/или активированный фактор свертывания x
|
|
US20230192896A1
(en)
*
|
2016-11-23 |
2023-06-22 |
Bioverativ Therapeutics Inc. |
Bispecific antibodies binding to coagulation factor ix and coagulation factor x
|
|
EP3577140A1
(en)
|
2017-02-01 |
2019-12-11 |
Novo Nordisk A/S |
Procoagulant antibodies
|
|
US20210284715A1
(en)
|
2017-02-06 |
2021-09-16 |
Applied Stemcell, Inc. |
Coagulation factor viii mimetic protein and uses thereof
|
|
IL270138B2
(en)
*
|
2017-04-26 |
2025-08-01 |
Eureka Therapeutics Inc |
Structures that specifically recognize glypican 3 and their uses
|
|
EP3621643A4
(en)
|
2017-05-11 |
2021-07-21 |
Atreca, Inc. |
ANTIBODY ANTI-MALARIA BOUND WITH CIRCUMSPOROZOID PROTEIN
|
|
GB201709970D0
(en)
|
2017-06-22 |
2017-08-09 |
Kymab Ltd |
Bispecific antigen-binding molecules
|
|
AR113142A1
(es)
|
2017-09-29 |
2020-01-29 |
Chugai Pharmaceutical Co Ltd |
Moléculas de unión al antígeno multiespecíficas que tienen actividad de sustitución de la función de cofactor del factor viii de coagulación de sangre (fviii), y formulaciones farmacéuticas que contienen dicha molécula como ingrediente activo
|
|
US11787874B2
(en)
|
2017-11-15 |
2023-10-17 |
Novo Nordisk A/S |
Factor X binders enhancing FX activation
|
|
PL3723858T3
(pl)
*
|
2018-12-21 |
2022-03-07 |
Kymab Limited |
Przeciwciało dwuswoiste fixaxfx o wspólnym łańcuchu lekkim
|